Xtant Medical Holdings, Inc.

XTNT Healthcare Medical Devices

Xtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024.

Revenue
−35.0%
EPS
−333.3%
Free cash flow
−882.0%
Total debt
−33.0%

Quarter to June 2026, against a year earlier

0.29 0.01 −3.33%
Market cap
$42.1M
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
8/9
Altman Z
0.03
Beneish M
−3.11
Dividend safety
n/a

Xtant Medical Holdings, Inc. (XTNT) P/E ratio

Alert me on P/E ratio

Xtant Medical Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 139× (December 2023) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 19.1× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 27.5× 43.59%
Dec 2025 19.1× (40.00%)
Sep 2025 31.9× —
42 more quarters

Against its own ten years

Low 0.0× High 139×
Ten-year median 0.0×
Current reading's percentile 87

P/E ratio against peers

Company P/E ratio
MDAI Spectral AI, Inc. compare n/m
TELA TELA Bio, Inc. compare n/m
CVRX CVRx, Inc. compare n/m
RPID Rapid Micro Biosystems, Inc. compare n/m
MYO Myomo, Inc. compare n/m
NSPR InspireMD, Inc. compare n/m
XTNT Xtant Medical Holdings, Inc. n/m
ELUT Elutia Inc. compare 0.6×
SNWV Sanuwave Health Inc. compare 1.3×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on XTNT